Institutional shares held 76.1 Million
176K calls
284K puts
Total value of holdings $34.1B
$78.6M calls
$127M puts
Market Cap $37.3B
83,253,696 Shares Out.
Institutional ownership 91.39%
# of Institutions 1,204


Latest Institutional Activity in IDXX

Top Purchases

Q3 2024
International Assets Investment Management, LLC Shares Held: 528K ($237M)
Q3 2024
Vontobel Holding Ltd. Shares Held: 220K ($98.6M)
Q3 2024
Assenagon Asset Management S.A. Shares Held: 119K ($53.3M)
Q3 2024
Wealth Enhancement Advisory Services, LLC Shares Held: 29.6K ($13.3M)
Q3 2024
Bsn Capital Partners LTD Shares Held: 15.9K ($7.14M)

Top Sells

Q3 2024
Sg Americas Securities, LLC Shares Held: 25.4K ($11.4M)
Q3 2024
Raymond James & Associates Shares Held: 57.4K ($25.7M)
Q3 2024
Allspring Global Investments Holdings, LLC Shares Held: 23.2K ($10.4M)
Q3 2024
New York State Common Retirement Fund Shares Held: 80.9K ($36.2M)
Q3 2024
Stephens Investment Management Group LLC Shares Held: 105K ($47M)

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.


Insider Transactions at IDXX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
630K Shares
From 23 Insiders
Exercise of conversion of derivative security 95.6K shares
Grant, award, or other acquisition 1.43K shares
Bona fide gift 533K shares
Sell / Disposition
628K Shares
From 21 Insiders
Payment of exercise price or tax liability 5.05K shares
Open market or private sale 72.5K shares
Bona fide gift 550K shares

Track Institutional and Insider Activities on IDXX

Follow IDEXX LABORATORIES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDXX shares.

Notify only if

Insider Trading

Get notified when an Idexx Laboratories Inc insider buys or sells IDXX shares.

Notify only if

News

Receive news related to IDEXX LABORATORIES INC

Track Activities on IDXX